APC-Cy™7 Rat Anti-Mouse CD8a

产品名称:APC-Cy™7 大鼠抗小鼠 CD8a 抗体；APC-Cy™7 Rat Anti-Mouse CD8a

中文名称:APC-Cy™7 大鼠抗小鼠 CD8a 抗体

英文名称:APC-Cy™7 Rat Anti-Mouse CD8a

APC-Cy™7 Rat Anti-Mouse CD8a 产品介绍：

Material Number: 557654
Alternate Name: Ly-2, Lyt-2
Size: 0.1 mg
Concentration: 0.2 mg/ml
Clone: 53-6.7
Immunogen: Mouse thymus / spleen Cells
Isotype: Rat (LOU) IgG2a, κ
Reactivity: QC Testing: Mouse
Storage Buffer: Aqueous buffered solution containing ≤0.09% sodium azide.

Description
The 53-6.7 antibody has been reported to react with the 38 kDa α and 34 kDa α' chains of the CD8 differentiation antigen (Ly-2 or Lyt-2) of 
all mouse strains tested. The CD8 α and α' chains (CD8a) form heterodimers with the CD8 β chain (CD8b, Ly-3, or Lyt-3) on the surface of 
most thymocytes. A subpopulation of mature T lymphocytes (i.e., MHC class I-restricted T cells, including most T suppressor/cytotoxic cells) 
expresses almost exclusively the CD8 αβ heterodimer (the α' chain is absent). Subsets of γδ TCR-bearing T cells, intestinal intrapithelial 
lymphocytes, and dendritic cells express CD8a without CD8b. It has been suggested that the expression of the CD8a/CD8b heterodimer is 
restricted to T lymphocytes which matured in the thymus or in an extrathymic environment that had been influenced by thymus-initiated 
neuroendocrine signals. CD8 is an antigen coreceptor on the T-cell surface which interacts with MHC class I molecules on antigen-presenting 
cells or epithelial cells. It participates in T-cell activation through its association with the T-cell receptor complex and protein tyrosine kinase 
lck (p56 [lck]). The CD8 α and α' chains arise from alternatively spliced messengers of a single CD8a gene. The longer α form associates with 
p56 [lck] via a CXCP motif in its cytoplasmic domain, which it shares with CD4, but not with CD8b. The truncated α' chain is unable to 
associate with p56 [lck], and it may function to attenuate the CD8-mediated costimulatory signal during intrathymic T-cell maturation. In vivo 
and in vitro treatment with 53-6.7 mAb has reportedly been effective at depleting CD8+ peripheral T lymphocytes. The 53-6.7 antibody has 
also been reported to cross-reaact with CD8 α- and α'-like polypeptides on subsets of thymic and peripheral lymphocytes in the Egyptian toad, 
Bufo regularis.

The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
The antibody was conjugated with APC-Cy7 under optimum conditions, and unconjugated antibody and free APC-Cy7 were removed.
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.